Medtronic (NYSE:MDT) added strength Monday morning, after being upgraded to overweight from equal weight by Wells Fargo. The Wall Street firm expects Medtronic to benefit from a maturing product pipeline and improving medtech trends.
Friday, the .
Available in Europe since 2020, this new system delivers the strongest clinical outcomes and best user experience to-date within the Medtronic family of pumps
DUBLIN, April 21, 2023 /PRNewswire/. | April 21, 2023
/PRNewswire/ Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval of its.
The diaTribe team was on-the-ground in Barcelona, Spain to cover the latest news in diabetes technology from the ATTD 2022 international conference. Here are our top highlights.